Startups
Nimbus Therapeutics
Clinical-stage biotechnology company using computational chemistry, structure-based design and machine learning to discover and develop investigational small molecule medicines. Its programs target cancer, immunological and metabolic diseases. Founded as Nimbus Discovery in 2009 and renamed Nimbus Therapeutics in 2015; headquartered in Boston.
Founded 2009
Team
 Abbas KazimiChief Executive Officer · Board Director |
 Anita ScheuberSenior Vice President, Clinical Development |
Anne McGeorgeBoard Director |
 Avinash PhadkeVice President, CMC |
 Bruce BoothChairman and Co-Founder |
 Cindy FungVice President, Corporate Affairs and Communications |
 Dan PriceVice President, Computational Chemistry & Structural Biology |
 Fang WangSenior Vice President, Biology |
 George P. VlasukBoard Director |
 Ian SandersonChief Financial Officer |
 Jean GeorgeBoard Director |
 Joshua RothVice President, Intellectual Property |
Katharine KnobilBoard Director |
 Laura StoppelBoard Director |
 Mark IwickiBoard Director |
 Michael AckerVice President, Molecular Sciences |
 Neelu KailaVice President, Medicinal Chemistry |
 Peter J. TumminoPresident of Research & Development |
Rajeev DadooBoard Director |
 Scott EdmondsonSenior Vice President, Chemistry |
 Sekhar SurapaneniVice President, DMPK and Clinical Pharmacology |
 Steve SimmonsVice President, Information Technology |
 Todd BowserVice President, Program Management and R&D Strategic Operations |